|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bright NJ, Thornton C and Carling D: The
regulation and function of mammalian AMPK-related kinases. Acta
Physiol (Oxf). 196:15–26. 2009. View Article : Google Scholar
|
|
3
|
Shackelford DB and Shaw RJ: The LKB1-AMPK
pathway: metabolism and growth control in tumour suppression. Nat
Rev Cancer. 9:563–575. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fu A and Screaton RA: Using kinomics to
delineate signaling pathways: control of CRTC2/TORC2 by the AMPK
family. Cell Cycle. 7:3823–3828. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mirouse V, Swick LL, Kazgan N, St Johnston
D and Brenman JE: LKB1 and AMPK maintain epithelial cell polarity
under energetic stress. J Cell Biol. 177:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Klijn JG, Zhang Y, Sieuwerts AM,
Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME and
Yu J: Gene-expression profiles to predict distant metastasis of
lymph-node-negative primary breast cancer. Lancet. 365:671–679.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chin K, DeVries S, Fridlyand J, Spellman
PT, Roydasgupta R, Kuo WL, Lapuk A, Neve RM, Qian Z, Ryder T, et
al: Genomic and transcriptional aberrations linked to breast cancer
patho-physiologies. Cancer Cell. 10:529–541. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu X, Lu X, Wang ZC, Iglehart JD, Zhang X
and Richardson AL: Predicting features of breast cancer with gene
expression patterns. Breast Cancer Res Treat. 108:191–201. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cheng H, Liu P, Wang ZC, Zou L, Santiago
S, Garbitt V, Gjoerup OV, Iglehart JD, Miron A, Richardson AL, et
al: SIK1 couples LKB1 to p53-dependent anoikis and suppresses
metastasis. Sci Signal. 2:ra352009.PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Müller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Farh KK, Grimson A, Jan C, Lewis BP,
Johnston WK, Lim LP, Burge CB and Bartel DP: The widespread impact
of mammalian MicroRNAs on mRNA repression and evolution. Science.
310:1817–1821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang L, Deng T, Li X, Liu H, Zhou H, Ma
J, Wu M, Zhou M, Shen S, Li X, et al: MicroRNA-141 is involved in a
nasopharyngeal carcinoma-related genes network. Carcinogenesis.
31:559–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shi L, Wu L, Chen Z, Yang J, Chen X, Yu F,
Zheng F and Lin X: MiR-141 activates Nrf2-dependent antioxidant
pathway via down-regulating the expression of Keap1 conferring the
resistance of hepatocellular carcinoma cells to 5-fluorouracil.
Cell Physiol Biochem. 35:2333–2348. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Jaarsveld MT, Helleman J, Boersma AW,
van Kuijk PF, van Ijcken WF, Despierre E, Vergote I, Mathijssen RH,
Berns EM, Verweij J, et al: miR-141 regulates KEAP1 and modulates
cisp-latin sensitivity in ovarian cancer cells. Oncogene.
32:4284–4293. 2013. View Article : Google Scholar
|
|
19
|
Yuan ZQ, Sun M, Feldman RI, Wang G, Ma X,
Jiang C, Coppola D, Nicosia SV and Cheng JQ: Frequent activation of
AKT2 and induction of apoptosis by inhibition of
phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer.
Oncogene. 19:2324–2330. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang L, Chen F, Pang EJ, Zhang ZQ, Jin BW
and Dong WF: microRNA-182 inhibits proliferation through targeting
oncogenic ANUBL1 in gastric cancer. Oncol Rep. 33:1707–1716.
2015.PubMed/NCBI
|
|
21
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin
and cancer metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
22
|
Curley MD, Therrien VA, Cummings CL,
Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden
DT, Rueda BR and Foster R: CD133 expression defines a tumor
initiating cell population in primary human ovarian cancer. Stem
Cells. 27:2875–2883. 2009.PubMed/NCBI
|
|
23
|
Yoshida A, Rzhetsky A, Hsu LC and Chang C:
Human aldehyde dehydrogenase gene family. Eur J Biochem.
251:549–557. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Storms RW, Trujillo AP, Springer JB, Shah
L, Colvin OM, Ludeman SM and Smith C: Isolation of primitive human
hematopoietic progenitors on the basis of aldehyde dehydrogenase
activity. Proc Natl Acad Sci USA. 96:9118–9123. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hess DA, Meyerrose TE, Wirthlin L, Craft
TP, Herrbrich PE, Creer MH and Nolta JA: Functional
characterization of highly purified human hematopoietic
repopulating cells isolated according to aldehyde dehydrogenase
activity. Blood. 104:1648–1655. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Armstrong L, Stojkovic M, Dimmick I, Ahmad
S, Stojkovic P, Hole N and Lako M: Phenotypic characterization of
murine primitive hematopoietic progenitor cells isolated on basis
of aldehyde dehydrogenase activity. Stem Cells. 22:1142–1151. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gentry T, Foster S, Winstead L, Deibert E,
Fiordalisi M and Balber A: Simultaneous isolation of human BM
hematopoietic, endothelial and mesenchymal progenitor cells by flow
sorting based on aldehyde dehydrogenase activity: implications for
cell therapy. Cytotherapy. 9:259–274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Corti S, Locatelli F, Papadimitriou D,
Donadoni C, Salani S, Del Bo R, Strazzer S, Bresolin N and Comi GP:
Identification of a primitive brain-derived neural stem cell
population based on aldehyde dehydrogenase activity. Stem Cells.
24:975–985. 2006. View Article : Google Scholar
|
|
29
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar
|
|
30
|
Ibarra I, Erlich Y, Muthuswamy SK,
Sachidanandam R and Hannon GJ: A role for microRNAs in maintenance
of mouse mammary epithelial progenitor cells. Genes Dev.
21:3238–3243. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Burger PE, Gupta R, Xiong X, Ontiveros CS,
Salm SN, Moscatelli D and Wilson EL: HighALDH activity: a novel
functional marker of murine prostate stem/progenitor cells. Stem
Cells Stem Cells. 27:2220–2228. 2009. View
Article : Google Scholar
|
|
32
|
Ross AA, Cooper BW, Lazarus HM, Mackay W,
Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D,
et al: Detection and viability of tumor cells in peripheral blood
stem cell collections from breast cancer patients using
immunocytochemical and clonogenic assay techniques. Blood.
82:2605–2610. 1993.PubMed/NCBI
|
|
33
|
Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO,
Zheng BJ and Guan XY: Identification and characterization of
tumorigenic liver cancer stem/progenitor cells. Gastroenterology.
132:2542–2556. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu C, Kelnar K, Liu B, Chen X,
Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, et
al: The microRNA miR-34a inhibits prostate cancer stem cells and
metastasis by directly repressing CD44. Nat Med. 17:211–215. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mateescu B, Batista L, Cardon M, Gruosso
T, de Feraudy Y, Mariani O, Nicolas A, Meyniel JP, Cottu P,
Sastre-Garau X and Mechta-Grigoriou F: miR-141 and miR-200a act on
ovarian tumorigenesis by controlling oxidative stress response. Nat
Med. 17:1627–1635. 2011. View
Article : Google Scholar : PubMed/NCBI
|
